Jennifer Moody is a cell therapy, business operations professional with 23 years of experience with stem cells, 12 of those years in industry commercializing products spanning from stem cell reagents to cell-based therapeutics. She obtained a BSc in Genetics from York University (Toronto), a PhD in Genetics from UBC (Vancouver), and pursued postdoctoral studies for 2.5 years at the Lund Stem Cell Centre in Lund, Sweden. From there she joined STEMCELL Technologies in Vancouver as an R&D scientist where she led commercial development of the TeSR product line. This was followed by almost 6 years at the Centre for the Commercialization of Regenerative Medicine (CCRM) in Toronto immersed in operations, alliance management and business development responsibilities. She is currently the Senior Director of Research Operations at BlueRock Therapeutics in Toronto fulfilling a dream to be part of building a regenerative cell therapy company to treat intractable diseases. She is a member of ISSCR, ISCT, serves on the ISCT Business Model and Investment subcommittee and is a member of the Rotman Business School Healthcare and Life Sciences Leadership Network.